BioCentury | Jul 10, 2019
Distillery Therapeutics

Reducing adipogenesis by fibroadipogenic precursors could treat limb-girdle muscular dystrophy

...published online June 3, 2019 doi:10.1038/s41467-019-10438-z CONTACT: Jyoti K. Jaiswal, Children's National Medical Center, Washington, D.C. email: jkjaiswal@cnmc.org Claire Quang Children's National Medical Center Annexin...
BioCentury | Oct 18, 2018
Distillery Therapeutics

Neurology

...Aug. 13, 2018 doi:10.1038/s41467-018-05656-w CONTACT: Vittorio Gallo, Children’s National Medical Center, Washington, D.C. email: vgallo@childrensnational.org Hongjiang Li Children's National Medical Center Stroke GABA...
BioCentury | Sep 15, 2016
Targets & Mechanisms

KOR-recting MS

...vitro and mouse studies suggest antagonizing ET1 could increase differentiation of OPCs to promote remyelination Children's National Medical Center...
BioCentury | May 25, 2015
Emerging Company Profile

Dimension's intentions

...2013 by Thomas Beck, James Wilson and Ben Auspitz University collaborators: University of Pennsylvania , Children's National Medical Center...
BioCentury | Feb 5, 2015
Distillery Therapeutics

Therapeutics: Neurofibromin 1 (NF1)

...DETAILS: Kim, E. et al. eLife; published online Dec. 23, 2014 doi:10.7554/eLife.05151 CONTACT: Yuan Zhu, Children's National Medical Center...
BioCentury | Feb 27, 2014
Distillery Therapeutics

Indication: Autoimmune disease

...unavailable Hammond, T.R. et al. Neuron; published online Feb. 5, 2014; doi:10.1016/j.neuron.2013.11.015 Contact: Vittorio Gallo, Children's National Medical Center...
BioCentury | Jan 23, 2014
Distillery Therapeutics

Indication: Neurology

...unavailable Scafidi, J. et al. Nature; published online Dec. 25, 2013; doi:10.1038/nature12880 Contact: Vittorio Gallo, Children's National Medical Center...
BioCentury | Feb 18, 2013
Company News

Summit, Children's National Medical Center deal

...EU to treat DMD (see BioCentury, Oct. 15, 2012). Summit Corp. plc (LSE:SUMM), Abingdon, U.K. Children's National Medical Center...
BioCentury | Jul 29, 2010
Distillery Therapeutics

Indication: Neurology

...J.L. et al. J. Neurosci.; published online July 21, 2010; doi:10.1523/JNEUROSCI.1714-10.2010 Contact: Molly M. Huntsman, Children's National Medical Center...
BioCentury | Nov 24, 2008
Regulation

Counting the oritavancin votes

...Medicine and Dentistry of New Jersey Yes No Yes Wiedermann, Bernhard VM Attending, Infectious Disease, Children's National Medical Center...
Items per page:
1 - 10 of 15
BioCentury | Jul 10, 2019
Distillery Therapeutics

Reducing adipogenesis by fibroadipogenic precursors could treat limb-girdle muscular dystrophy

...published online June 3, 2019 doi:10.1038/s41467-019-10438-z CONTACT: Jyoti K. Jaiswal, Children's National Medical Center, Washington, D.C. email: jkjaiswal@cnmc.org Claire Quang Children's National Medical Center Annexin...
BioCentury | Oct 18, 2018
Distillery Therapeutics

Neurology

...Aug. 13, 2018 doi:10.1038/s41467-018-05656-w CONTACT: Vittorio Gallo, Children’s National Medical Center, Washington, D.C. email: vgallo@childrensnational.org Hongjiang Li Children's National Medical Center Stroke GABA...
BioCentury | Sep 15, 2016
Targets & Mechanisms

KOR-recting MS

...vitro and mouse studies suggest antagonizing ET1 could increase differentiation of OPCs to promote remyelination Children's National Medical Center...
BioCentury | May 25, 2015
Emerging Company Profile

Dimension's intentions

...2013 by Thomas Beck, James Wilson and Ben Auspitz University collaborators: University of Pennsylvania , Children's National Medical Center...
BioCentury | Feb 5, 2015
Distillery Therapeutics

Therapeutics: Neurofibromin 1 (NF1)

...DETAILS: Kim, E. et al. eLife; published online Dec. 23, 2014 doi:10.7554/eLife.05151 CONTACT: Yuan Zhu, Children's National Medical Center...
BioCentury | Feb 27, 2014
Distillery Therapeutics

Indication: Autoimmune disease

...unavailable Hammond, T.R. et al. Neuron; published online Feb. 5, 2014; doi:10.1016/j.neuron.2013.11.015 Contact: Vittorio Gallo, Children's National Medical Center...
BioCentury | Jan 23, 2014
Distillery Therapeutics

Indication: Neurology

...unavailable Scafidi, J. et al. Nature; published online Dec. 25, 2013; doi:10.1038/nature12880 Contact: Vittorio Gallo, Children's National Medical Center...
BioCentury | Feb 18, 2013
Company News

Summit, Children's National Medical Center deal

...EU to treat DMD (see BioCentury, Oct. 15, 2012). Summit Corp. plc (LSE:SUMM), Abingdon, U.K. Children's National Medical Center...
BioCentury | Jul 29, 2010
Distillery Therapeutics

Indication: Neurology

...J.L. et al. J. Neurosci.; published online July 21, 2010; doi:10.1523/JNEUROSCI.1714-10.2010 Contact: Molly M. Huntsman, Children's National Medical Center...
BioCentury | Nov 24, 2008
Regulation

Counting the oritavancin votes

...Medicine and Dentistry of New Jersey Yes No Yes Wiedermann, Bernhard VM Attending, Infectious Disease, Children's National Medical Center...
Items per page:
1 - 10 of 15